Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The prognosis of nasopharyngeal carcinoma (NPC) patients with parotid lymph node (PLN) metastasis remains unclear. This study was performed to investigate the prognostic significance and optimal staging category of PLN metastasis and develop a nomogram for estimating individual risk. Materials and Methods Clinical data of 7,084 non-metastatic NPC patients were retrospectively reviewed. Overall survival (OS) was the primary endpoint. A nomogram was established based on the Cox proportional hazards regression model. The accuracy and calibration ability of this nomogram was evaluated by C-index and calibration curves with bootstrap validation. Results Totally, 164/7,084 NPC patients (2.3%) presented with PLNs. Multivariate analyses showed that PLN metastasis was a negative prognostic factor for OS, progression-free survival (PFS), distant metastasis-free survival (DMFS), and locoregional relapse-free survival (LRFS). Patients with PLN metastasis had a worse prognosis than N3 disease. Five independent prognostic factors were included in the nomogram, which showed a C-index of 0.743. The calibration curves for probability of 3- and 5-year OS indicated satisfactory agreement between nomogram-based prediction and actual observation. All results were confirmed in the validation cohort. Conclusion NPC patient with PLN metastasis had poorer survival outcome (OS, PFS, DMFS, and LRFS) than N3 disease. We developed a nomogram to provide individual prediction of OS for patients with PLN metastasis.
Abstract
Purpose The prognosis of nasopharyngeal carcinoma (NPC) patients with parotid lymph node (PLN) metastasis remains unclear. This study was performed to investigate the prognostic significance and optimal staging category of PLN metastasis and develop a nomogram for estimating individual risk. Materials and Methods Clinical data of 7,084 non-metastatic NPC patients were retrospectively reviewed. Overall survival (OS) was the primary endpoint. A nomogram was established based on the Cox proportional hazards regression model. The accuracy and calibration ability of this nomogram was evaluated by C-index and calibration curves with bootstrap validation. Results Totally, 164/7,084 NPC patients (2.3%) presented with PLNs. Multivariate analyses showed that PLN metastasis was a negative prognostic factor for OS, progression-free survival (PFS), distant metastasis-free survival (DMFS), and locoregional relapse-free survival (LRFS). Patients with PLN metastasis had a worse prognosis than N3 disease. Five independent prognostic factors were included in the nomogram, which showed a C-index of 0.743. The calibration curves for probability of 3- and 5-year OS indicated satisfactory agreement between nomogram-based prediction and actual observation. All results were confirmed in the validation cohort. Conclusion NPC patient with PLN metastasis had poorer survival outcome (OS, PFS, DMFS, and LRFS) than N3 disease. We developed a nomogram to provide individual prediction of OS for patients with PLN metastasis.
참고문헌 (30)
- Cao SM, "The prevalence and prevention of nasopharyngeal carcinoma in China", Chin J Cancer, 30, pp.114~119 (2011)
- Simons MJ, "The origin of genetic risk for nasopharyngeal carcinoma : a commentary on : is nasopharyngeal cancer really a"Cantonese cancer"", Chin J Cancer, 29, pp.527~537 (2010)
- Ho FC, "Patterns of regional lymph node metastasis of nasopharyngeal carcinoma : a meta-analysis of clinical evidence", BMC Cancer, 12, pp.98~ (2012)
- Tang L, "The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma : analysis of the spread patterns in lymph nodes by magnetic resonance imaging", Cancer, 115, pp.680~688 (2009)
- King AD, "Neck node metastases from nasopharyngeal carcinoma : MR imaging of patterns of disease", Head Neck, 22, pp.275~281 (2000)
- Wang X, "Patterns of level II node metastasis in nasopharyngeal carcinoma", Radiother Oncol, 89, pp.28~32 (2008)
- Chong VF, "Parotid gland involvement in nasopharyngeal carcinoma", J Comput Assist Tomogr, 23, pp.524~528 (1999)
- Kwong DL, "Intensity-modulated radiotherapy for earlystage nasopharyngeal carcinoma : a prospective study on disease control and preservation of salivary function", Cancer, 101, pp.1584~1593 (2004)
- Kam MK, "Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients", J Clin Oncol, 25, pp.4873~4879 (2007)
- Cannon DM, "Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer", Int J Radiat Oncol Biol Phys, 70, pp.660~665 (2008)
- Cao CN, "Recurrence of nasopharyngeal carcinoma in the parotid region after definitive intensity-modulated radiotherapy", J Oral Maxillofac Surg, 71, pp.1993~1997 (2013)
- Lin DS, "Recurrence of nasopharyngeal carcinoma in the parotid region after parotidgland-sparing radiotherapy", J Formos Med Assoc, 110, pp.655~660 (2011)
- Pan JJ, "Proposal for the 8th edition of the AJCC", UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy, 2016, pp.122, 546~558
- Amin MB, "AJCC cancer staging manual" (2017), Springer International Publishing
- Zhang Y, "Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy", Sci Rep, 5, pp.13919~ (2015)
- Xu Y, "Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma : a propensity score matching study", Cancer Med, 6, pp.2213~2221 (2017)
- Gregoire V, "Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines", Radiother Oncol, 110, pp.172~181 (2014)
- van den Brekel MW, "Cervical lymph node metastasis : assessment of radiologic criteria", Radiology, 177, pp.379~384 (1990)
- Tang L, "Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging : prognostic value and staging categories", Cancer, 113, pp.347~354 (2008)
- Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)", Eur J Cancer, 45, pp.228~247 (2009)
- Lee AW, "Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma", Radiother Oncol, 87, pp.204~210 (2008)
- Lin S, "Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma : experience of 370 consecutive cases", BMC Cancer, 10, pp.39~ (2010)
- Yu Z, "Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma", Ai Zheng, 28, pp.1132~1137 (2009)
- Tang LL, "Validation of the 8th edition of the UICC", AJCC staging system for nasopharyngeal carcinoma from endemic areas in the intensity-modulated radiotherapy era, 2017, pp.15, 913~919
- Cho JK, "Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients", Eur J Cancer, 51, pp.1303~1311 (2015)
- Tang LQ, "Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma", J Natl Cancer Inst, 108, pp.djv291~ (2016)
- Song C, "A meta-analysis on the EBV DNA and VCAIgA in diagnosis of Nasopharyngeal Carcinoma", Pak J Med Sci, 29, pp.885~890 (2013)
- Lin JC, "Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma", N Engl J Med, 350, pp.2461~2470 (2004)
- Chan AT, "Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma", J Natl Cancer Inst, 94, pp.1614~1619 (2002)
- Wang WY, "Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic", recurrent nasopharyngeal carcinoma, 2010, pp.16, 1016~1024